You have 9 free searches left this month | for more free features.

Primary Hyperoxaluria (PH)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Hyperoxaluria Type 1 (PH1) Trial (Nedosiran)

Available
  • Primary Hyperoxaluria Type 1 (PH1)
  • (no location specified)
Aug 7, 2023

PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)

Active, not recruiting
  • PH1
  • +4 more
  • Bordeaux, France
  • +8 more
Jan 13, 2023

Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

Enrolling by invitation
  • Primary Hyperoxaluria Type 1 (PH1)
  • +5 more
  • San Francisco, California
  • +19 more
Jun 22, 2022

Study of Patients With Primary Hyperoxaluria Type 1 (PH1)

Recruiting
  • Primary Hyperoxaluria Type 1
    • Phoenix, Arizona
    • +10 more
    Aug 11, 2022

    Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 Trial in Worldwide (nedosiran)

    Not yet recruiting
    • Primary Hyperoxaluria
    • +2 more
    • (no location specified)
    Sep 8, 2021

    Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Placebo, Lumasiran)

    Active, not recruiting
    • Primary Hyperoxaluria Type 1 (PH1)
    • San Diego, California
    • +15 more
    Mar 4, 2022

    Primary Hyperoxaluria Type 3 Trial in Worldwide (DCR-PHXC, Sterile Normal Saline (0.9% NaCl))

    Completed
    • Primary Hyperoxaluria Type 3
    • Boston, Massachusetts
    • +5 more
    Sep 9, 2021

    Primary Hyperoxaluria Type 3 Trial in Worldwide

    Recruiting
    • Primary Hyperoxaluria Type 3
      • Boston, Massachusetts
      • +12 more
      Nov 16, 2021

      Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)

      Recruiting
      • Cystinosis
      • Primary Hyperoxaluria
      • Diagnostic test
      • Hanover, Lower Saxony, Germany
        Screening Laboratory Hanover
      Apr 24, 2023

      Rare Kidney Stone Consortium Patient Registry

      Recruiting
      • Primary Hyperoxaluria
      • +3 more
        • Rochester, Minnesota
        • +3 more
        Aug 19, 2022

        Primary Hyperoxaluria Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes HC-1, Placebo)

        Completed
        • Primary Hyperoxaluria
        • Oxabact OC5 - Oxalobacter formigenes HC-1
        • Placebo
        • Nashville, Tennessee
        • +9 more
        Dec 9, 2021

        Primary Hyperoxaluria Trial in Bonn (Oxalobacter formigenes)

        Completed
        • Primary Hyperoxaluria
        • Oxalobacter formigenes
        • Bonn, Germany
          Universitätsklinikum Bonn, Department of Paediatric Nephrology
        Dec 9, 2021

        Hyperoxaluria, Primary Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes Strain HC-1)

        Terminated
        • Hyperoxaluria, Primary
        • Oxabact OC5 - Oxalobacter formigenes Strain HC-1
        • Nashville, Tennessee
        • +7 more
        Nov 11, 2021

        Phenotyping of Primary Hyperoxaluria

        Recruiting
        • Primary Hyperoxaluria
          • Strasbourg, France
            Service de Néphrologie et Transplantation - Hôpitaux Universitai
          Oct 25, 2021

          Rare Kidney Stone Consortium Biobank

          Recruiting
          • Primary Hyperoxaluria
          • +3 more
            • Rochester, Minnesota
              Mayo Clinic
            Jul 8, 2021

            Primary Hyperoxaluria, Cystinuria, Adenine Phosphoribosyl Transferase Deficiency Trial in Rochester, New York, Reykjavik

            Completed
            • Primary Hyperoxaluria
            • +3 more
            • Health-related Quality of Life in Rare Kidney Stone Questionnaire
            • Rochester, Minnesota
            • +2 more
            Aug 31, 2022

            Prospective Research Rare Kidney Stones (ProRKS)

            Recruiting
            • Hyperoxaluria
            • +4 more
              • Birmingham, Alabama
              • +10 more
              Nov 10, 2022

              Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Lumasiran, Placebo)

              Completed
              • Primary Hyperoxaluria Type 1 (PH1)
              • Bordeaux, France
              • +8 more
              Jan 22, 2020

              Primary Hyperoxaluria Trial in Paris (stiripentol (Diacomit))

              Completed
              • Primary Hyperoxaluria
              • stiripentol (Diacomit)
              • Paris, France
              • +2 more
              Mar 25, 2021

              Adhesive Dental Trial in London (Tetranite Implant Stabilization Material)

              Not yet recruiting
              • Adhesive Dental
              • Tetranite Implant Stabilization Material
              • London, United Kingdom
                Norton Implants
              Sep 9, 2022

              Proteomics of Primary Hyperoxaluria Type 1

              Completed
              • Primary Hyperoxaluria Type 1
              • Observational
              • (no location specified)
              Jun 10, 2019

              Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)

              Recruiting
              • Hyperoxaluria
              • +2 more
              • BMN 255
              • Placebo
              • Birmingham, Alabama
              • +6 more
              Nov 16, 2023

              High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

              Not yet recruiting
              • High Grade Ovarian Cancer
              • +2 more
              • (no location specified)
              Jul 11, 2022